JP2024510900A5 - - Google Patents
Info
- Publication number
- JP2024510900A5 JP2024510900A5 JP2023551754A JP2023551754A JP2024510900A5 JP 2024510900 A5 JP2024510900 A5 JP 2024510900A5 JP 2023551754 A JP2023551754 A JP 2023551754A JP 2023551754 A JP2023551754 A JP 2023551754A JP 2024510900 A5 JP2024510900 A5 JP 2024510900A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- acid sequence
- nucleotide sequence
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163153879P | 2021-02-25 | 2021-02-25 | |
| US63/153,879 | 2021-02-25 | ||
| US202163263231P | 2021-10-28 | 2021-10-28 | |
| US63/263,231 | 2021-10-28 | ||
| US202263309380P | 2022-02-11 | 2022-02-11 | |
| US63/309,380 | 2022-02-11 | ||
| PCT/US2022/017733 WO2022182890A1 (en) | 2021-02-25 | 2022-02-24 | Codon-optimized nucleotide sequences encoding an ap-1 transcription factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510900A JP2024510900A (ja) | 2024-03-12 |
| JP2024510900A5 true JP2024510900A5 (cg-RX-API-DMAC7.html) | 2025-03-19 |
Family
ID=80999862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023551754A Pending JP2024510900A (ja) | 2021-02-25 | 2022-02-24 | Ap-1転写因子をコードするコドン最適化ヌクレオチド配列 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12270032B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4298230A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024510900A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230150834A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022226655A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3174248A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022182890A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4121447A1 (en) | 2020-03-20 | 2023-01-25 | Lyell Immunopharma, Inc. | Novel recombinant cell surface markers |
| EP4298230A1 (en) | 2021-02-25 | 2024-01-03 | Lyell Immunopharma, Inc. | Codon-optimized nucleotide sequences encoding an ap-1 transcription factor |
| AU2022227686A1 (en) | 2021-02-25 | 2023-07-27 | Lyell Immunopharma, Inc. | Ror1 targeting chimeric antigen receptor |
| JPWO2025089255A1 (cg-RX-API-DMAC7.html) * | 2023-10-23 | 2025-05-01 | ||
| WO2025131119A1 (en) * | 2023-12-22 | 2025-06-26 | Everest Medicines (China) Co., Ltd. | Cancer vaccines and uses thereof |
| WO2025184170A1 (en) * | 2024-02-27 | 2025-09-04 | Overt Bio, Inc. | Methods and compositions for improving t cell function in an immunosuppressive environment |
| WO2025199252A1 (en) * | 2024-03-19 | 2025-09-25 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Inducible transcription factor expression for modulating immune cell function |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US20090226474A1 (en) | 2004-05-27 | 2009-09-10 | Weidanz Jon A | Antibodies as T cell receptor mimics, methods of production and uses thereof |
| CN101851668A (zh) | 2009-08-10 | 2010-10-06 | 芮屈生物技术(上海)有限公司 | 一种ap-1基因的原位杂交检测试剂盒及其检测方法和应用 |
| JP5956342B2 (ja) | 2009-11-03 | 2016-07-27 | シティ・オブ・ホープCity of Hope | 形質導入T細胞選択のためのトランケート上皮増殖因子レセプタ(EGFRt) |
| WO2013151664A1 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| AU2016251687C1 (en) * | 2015-04-22 | 2023-07-27 | CureVac SE | RNA containing composition for treatment of tumor diseases |
| GB201515351D0 (en) | 2015-08-28 | 2015-10-14 | Cancer Res Technology | Antibody |
| CN106636210B (zh) | 2016-10-09 | 2019-07-19 | 广州暨南大学医药生物技术研究开发中心 | 转录因子组合诱导成纤维细胞转分化为类睾丸间质细胞的方法 |
| GB201621889D0 (en) | 2016-12-21 | 2017-02-01 | Autolus Ltd | Cell |
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| WO2018200582A1 (en) | 2017-04-26 | 2018-11-01 | Eureka Therapeutics, Inc. | Chimeric antibody/t-cell receptor constructs and uses thereof |
| EP3723774A4 (en) | 2017-12-15 | 2021-09-08 | The Board of Trustees of the Leland Stanford Junior University | COMPOSITIONS AND METHODS OF INHIBITION OF T-CELL EXHAUSTATION |
| EP3830114A4 (en) | 2018-07-31 | 2022-08-03 | Washington University | USE OF INTERLEUKIN-7 AND CHIMERA ANTIGEN RECEPTOR (CAR) IMMUNE EFFECTOR CELLS FOR TUMOR TREATMENT |
| MX2021013218A (es) | 2019-05-01 | 2021-12-10 | Pact Pharma Inc | Composiciones y metodos para el tratamiento del cancer usando una terapia con celulas t modificadas con tet2. |
| AU2021205416B2 (en) * | 2020-01-08 | 2026-08-06 | Obsidian Therapeutics, Inc. | Compositions and methods for tunable regulation of transcription |
| EP4298230A1 (en) | 2021-02-25 | 2024-01-03 | Lyell Immunopharma, Inc. | Codon-optimized nucleotide sequences encoding an ap-1 transcription factor |
| AU2022227686A1 (en) | 2021-02-25 | 2023-07-27 | Lyell Immunopharma, Inc. | Ror1 targeting chimeric antigen receptor |
-
2022
- 2022-02-24 EP EP22714031.6A patent/EP4298230A1/en active Pending
- 2022-02-24 US US17/679,977 patent/US12270032B2/en active Active
- 2022-02-24 WO PCT/US2022/017733 patent/WO2022182890A1/en not_active Ceased
- 2022-02-24 KR KR1020237032290A patent/KR20230150834A/ko active Pending
- 2022-02-24 CA CA3174248A patent/CA3174248A1/en active Pending
- 2022-02-24 AU AU2022226655A patent/AU2022226655A1/en not_active Abandoned
- 2022-02-24 JP JP2023551754A patent/JP2024510900A/ja active Pending
-
2025
- 2025-03-05 US US19/071,604 patent/US20250297268A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024518011A5 (cg-RX-API-DMAC7.html) | ||
| JP2022507830A5 (cg-RX-API-DMAC7.html) | ||
| DK2836511T3 (en) | POLYPEPTIDE TO BE USED FOR ADOPTIVE CELL THERAPY | |
| JP2024507996A5 (cg-RX-API-DMAC7.html) | ||
| JP2024518011A (ja) | 多様な免疫細胞のための単鎖および多鎖合成抗原受容体 | |
| JP2023518049A5 (cg-RX-API-DMAC7.html) | ||
| JP2021532742A5 (cg-RX-API-DMAC7.html) | ||
| FI3844267T3 (fi) | Menetelmät kimeeristä antigeenireseptoria ilmentävien solujen valmistamiseksi | |
| JP2017504601A5 (cg-RX-API-DMAC7.html) | ||
| IL273201B1 (en) | Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy | |
| US20190031759A1 (en) | Chimeric antigen receptors and methods of their use | |
| JP2022545167A5 (cg-RX-API-DMAC7.html) | ||
| JP2019518424A5 (cg-RX-API-DMAC7.html) | ||
| RU2018122106A (ru) | Буферы для стабилизации лентивирусных препаратов | |
| JP2022512913A5 (cg-RX-API-DMAC7.html) | ||
| WO2017176525A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| CN110511912A (zh) | 免疫细胞的功能调节 | |
| WO2021096868A1 (en) | Engineered t cell receptors and uses thereof | |
| JP2023548467A5 (cg-RX-API-DMAC7.html) | ||
| JP2023549098A5 (cg-RX-API-DMAC7.html) | ||
| JP2023548829A5 (cg-RX-API-DMAC7.html) | ||
| JP2023518293A (ja) | 新規の組換え細胞表面マーカー | |
| CN115427554A (zh) | 扩增t细胞治疗癌症和相关恶性肿瘤的方法 | |
| IL312302A (en) | Methods for creating cells | |
| CA3174248A1 (en) | Codon-optimized nucleotide sequences encoding an ap-1 transcription factor |